Roberto Abadie

732 total citations
39 papers, 429 citations indexed

About

Roberto Abadie is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Roberto Abadie has authored 39 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 17 papers in Infectious Diseases and 17 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Roberto Abadie's work include HIV, Drug Use, Sexual Risk (27 papers), HIV/AIDS Research and Interventions (16 papers) and Opioid Use Disorder Treatment (10 papers). Roberto Abadie is often cited by papers focused on HIV, Drug Use, Sexual Risk (27 papers), HIV/AIDS Research and Interventions (16 papers) and Opioid Use Disorder Treatment (10 papers). Roberto Abadie collaborates with scholars based in United States, Puerto Rico and Canada. Roberto Abadie's co-authors include Kirk Dombrowski, Carl Elliott, Camila Gelpí-Acosta, Bilal Khan, Celia B. Fisher, Juan Carlos Reyes, Patrick Habecker, Shira M. Goldenberg, Ric Curtis and Brandon Brown and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Roberto Abadie

36 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Abadie United States 12 219 204 102 96 62 39 429
J.P. Moatti France 10 136 0.6× 192 0.9× 118 1.2× 92 1.0× 21 0.3× 23 366
Emanuel Krebs Canada 16 277 1.3× 445 2.2× 227 2.2× 121 1.3× 52 0.8× 49 631
David Otiashvili United States 12 161 0.7× 297 1.5× 87 0.9× 72 0.8× 60 1.0× 43 410
Christine A. Pace United States 14 327 1.5× 97 0.5× 98 1.0× 260 2.7× 53 0.9× 17 546
Dimitra Panagiotoglou Canada 12 101 0.5× 201 1.0× 154 1.5× 86 0.9× 65 1.0× 28 335
Irma Kirtadze United States 11 112 0.5× 277 1.4× 94 0.9× 91 0.9× 66 1.1× 41 383
Lyuba Azbel United States 15 237 1.1× 608 3.0× 360 3.5× 107 1.1× 222 3.6× 25 727
Risa Friedman United States 8 148 0.7× 331 1.6× 148 1.5× 176 1.8× 105 1.7× 8 453
Blanche Frank United States 10 120 0.5× 270 1.3× 116 1.1× 104 1.1× 47 0.8× 18 408
William R. Davis United States 12 183 0.8× 410 2.0× 141 1.4× 281 2.9× 149 2.4× 21 620

Countries citing papers authored by Roberto Abadie

Since Specialization
Citations

This map shows the geographic impact of Roberto Abadie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Abadie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Abadie more than expected).

Fields of papers citing papers by Roberto Abadie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Abadie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Abadie. The network helps show where Roberto Abadie may publish in the future.

Co-authorship network of co-authors of Roberto Abadie

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Abadie. A scholar is included among the top collaborators of Roberto Abadie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Abadie. Roberto Abadie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Adams, Seidu, Noèlia Carrasco-Querol, Kathy S. Chiou, et al.. (2024). Gut microbiota profiling in injection drug users with and without HIV-1 infection in Puerto Rico. Frontiers in Microbiology. 15. 1470037–1470037. 1 indexed citations
4.
Abadie, Roberto, M. Caleb Marlin, Andrew G. Chapple, et al.. (2023). Immune profiling in Puerto Rican injection drug users with and without HIV-1 infection. Journal of Leukocyte Biology. 114(2). 142–153. 2 indexed citations
6.
Abadie, Roberto, Manuel Cano, Patrick Habecker, & Camila Gelpí-Acosta. (2022). Substance use, injection risk behaviors, and fentanyl-related overdose risk among a sample of PWID post-Hurricane Maria. Harm Reduction Journal. 19(1). 129–129. 10 indexed citations
7.
Abadie, Roberto, Celia B. Fisher, & Kirk Dombrowski. (2021). “He's under oath”: Privacy and Confidentiality Views Among People Who Inject Drugs Enrolled in a Study of Social Networks and Human Immunodeficiency Virus/Hepatitis C Virus Risk. Journal of Empirical Research on Human Research Ethics. 16(3). 304–311.
8.
Abadie, Roberto, Katherine McLean, Patrick Habecker, & Kirk Dombrowski. (2021). Treatment trajectories and barriers in opioid agonist therapy for people who inject drugs in rural Puerto Rico. Journal of Substance Abuse Treatment. 127. 108347–108347. 10 indexed citations
9.
Abadie, Roberto. (2020). The Professional Guinea Pig. 1 indexed citations
10.
Abadie, Roberto & Kirk Dombrowski. (2020). “Caballo”: risk environments, drug sharing and the emergence of a hepatitis C virus epidemic among people who inject drugs in Puerto Rico. Harm Reduction Journal. 17(1). 85–85. 5 indexed citations
11.
Abadie, Roberto, et al.. (2020). COVID-19 risks among people who inject drugs in Puerto Rico. International Journal of Drug Policy. 93. 102903–102903. 11 indexed citations
12.
Abadie, Roberto, et al.. (2018). ‘It gives you nothing but it takes away everything’. SHILAP Revista de lepidopterología. 5(5). 71–80. 1 indexed citations
13.
Abadie, Roberto, et al.. (2018). Establishing trust in HIV/HCV research among people who inject drugs (PWID): Insights from empirical research. PLoS ONE. 13(12). e0208410–e0208410. 33 indexed citations
14.
Duncan, Ian, Ric Curtis, Juan Carlos Reyes, et al.. (2017). Hepatitis C serosorting among people who inject drugs in rural Puerto Rico. Preventive Medicine Reports. 6. 38–43. 11 indexed citations
15.
Duncan, Ian, Patrick Habecker, Roberto Abadie, et al.. (2017). Needle acquisition patterns, network risk and social capital among rural PWID in Puerto Rico. Harm Reduction Journal. 14(1). 69–69. 3 indexed citations
16.
Abadie, Roberto, et al.. (2016). Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico. Harm Reduction Journal. 13(1). 10–10. 41 indexed citations
17.
Abadie, Roberto. (2010). The Professional Guinea Pig. DigitalGeorgetown (Georgetown University Library). 60 indexed citations
18.
Abadie, Roberto, Audrey Weymiller, Jon C. Tilburt, et al.. (2009). Clinician's use of the Statin Choice decision aid in patients with diabetes: a videographic study nested in a randomized trial. Journal of Evaluation in Clinical Practice. 15(3). 492–497. 17 indexed citations
19.
Elliott, Carl & Roberto Abadie. (2008). Exploiting a Research Underclass in Phase 1 Clinical Trials. New England Journal of Medicine. 358(22). 2316–2317. 68 indexed citations
20.
Abadie, Roberto & Eileen Hoffman. (1992). Physician practices and attitudes on HIV-related issues: a survey of LSMS primary care physicians.. PubMed. 144(6). 283–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026